MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)

Ying X. Gue; Elon Correa; John L.P. Thompson; Shunichi Homma; Min Qian; Professor Gregory Lip

doi:10.2196/43822

Preprint2022

MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)

Ying X. Gue, Elon Correa, John L.P. Thompson, Shunichi Homma, Min Qian, Professor Gregory Lip

Article2023

Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Ying X. Gue, Elon Correa, John L.P. Thompson, Shunichi Homma, Min Qian, Professor Gregory Lip

Article2024

Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post‐hoc analysis of the <scp>WARCEF</scp> trial

Hironori Ishiguchi, Yang Chen, Bi Huang, Ying X. Gue, Elon Correa, S. Homma, John L.P. Thompson, Min Qian, Professor Gregory Lip, Azmil H. Abdul‐Rahim

Article2023

PREDICTING STROKE IN HEART FAILURE AND PRESERVED EJECTION FRACTION WITHOUT ATRIAL FIBRILLATION

Toru Kondo, Karola Jering, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo Maggioni, Felipe A. Martínez, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Scott D. Solomon, John J.V. McMurray

Article2023

Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation

Toru Kondo, Karola Jering, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo Maggioni, Felipe A. Martínez, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Margaret M. Redfield, Jean L. Rouleau, Dirk J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Scott D. Solomon, John J.V. McMurray

MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)

Discussion(0)

Related publications

MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint)

Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post‐hoc analysis of the <scp>WARCEF</scp> trial

PREDICTING STROKE IN HEART FAILURE AND PRESERVED EJECTION FRACTION WITHOUT ATRIAL FIBRILLATION

Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation